GlassScriptPhysician profile
Neda Dee Jooya
NPI 1588059638
$1,409.25
in general payments reported to CMS, 2019-2025
7 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $388 · 2022: $183 · 2023: $274 · 2024: $404 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786 · Education: $52.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.28 |
| Education | $52.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $740.69 | 2021-2025 | Lynparza, Enhertu |
| Glaxosmithkline, LLC. | $245.74 | 2022-2024 | Jemperli, Zejula |
| Intuitive Surgical, INC. | $153.49 | 2023 | |
| Tempus Ai, INC | $108.71 | 2025 | Xt Cdx |
| Seagen INC. | $74.62 | 2022 | |
| Myriad Genetic Laboratories, INC. | $60.30 | 2021 | |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neda Jooya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.